Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Citi
US Department of Justice
Novartis
Farmers Insurance
Johnson and Johnson
Merck
Julphar
Chubb

Generated: January 18, 2018

DrugPatentWatch Database Preview

LISINOPRIL AND HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

When do Lisinopril And Hydrochlorothiazide patents expire, and what generic alternatives are available?

Lisinopril And Hydrochlorothiazide is a drug marketed by Apotex Inc, Aurobindo, Hikma Intl Pharms, Invagen Pharms, Ivax Sub Teva Pharms, Lupin, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in thirteen NDAs.

The generic ingredient in LISINOPRIL AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; lisinopril. There are thirty-one drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.
Drug patent expirations by year for LISINOPRIL AND HYDROCHLOROTHIAZIDE
Pharmacology for LISINOPRIL AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for LISINOPRIL AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076007-002 Jul 1, 2002 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076262-002 Jul 1, 2002 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076007-003 Jul 1, 2002 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 075926-003 Jul 1, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076674-001 Oct 5, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 077912-003 Sep 27, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Prinston Inc LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076230-003 Jul 1, 2002 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076194-002 Jul 1, 2002 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Intl Pharms LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076265-001 Jul 8, 2002 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 075869-003 Jul 1, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Citi
US Army
Merck
McKinsey
QuintilesIMS
Argus Health
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot